PapersPMID:40327637
Effects of additional oral theophylline with inhaled therapy in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
What moved
1 findingHow to read these marks →“Seven studies with 1086 patients reported FEV1 showing a significant improvement of FEV1 in theophylline group with MD 0.08 (95% CI: 0.06 to 0.09, p<0.00001, I2 = 50%).”
- Study
- meta-analysis
- Participants
- 1,086
- Effect
- 0.08 mean difference, 95% CI 0.06 to 0.09
- Population
- Adults with stable COPD; pooled randomised trials of theophylline added to regular inhaled therapy (inhaled therapy continued in the comparator arms)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults with stable chronic obstructive pulmonary disease
- Participants
- 2,771
- Comparator
- no treatment
- Duration
- not reported
- Endpoints measured
- 12